169 related articles for article (PubMed ID: 7525190)
1. Potential immunological action of purine nucleoside analogues.
Dighiero G
Drugs; 1994; 47 Suppl 6():57-62. PubMed ID: 7525190
[TBL] [Abstract][Full Text] [Related]
2. Adverse and beneficial immunological effects of purine nucleoside analogues.
Dighiero G
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S75-81. PubMed ID: 9137960
[TBL] [Abstract][Full Text] [Related]
3. Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.
Robak T; Lech-Maranda E; Korycka A; Robak E
Curr Med Chem; 2006; 13(26):3165-89. PubMed ID: 17168705
[TBL] [Abstract][Full Text] [Related]
4. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
Saven A; Piro LD
Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
Pettitt AR
Br J Haematol; 2003 Jun; 121(5):692-702. PubMed ID: 12780783
[No Abstract] [Full Text] [Related]
6. Comparative effects of cladribine, fludarabine and pentostatin on nucleotide metabolism in T- and B-cell lines.
Wilson PK; Szabados E; Mulligan SP; Christopherson RI
Int J Biochem Cell Biol; 1998 Jul; 30(7):833-42. PubMed ID: 9722988
[TBL] [Abstract][Full Text] [Related]
7. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
8. Purine analogs in leukemia.
Lamanna N; Weiss M
Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
[No Abstract] [Full Text] [Related]
9. 2-Chloro-2'-deoxyadenosine (2CdA) biochemical aspects of antileukemic efficacy.
Fabianowska-Majewska K; Wyczechowska D
Acta Pol Pharm; 1996; 53(4):231-9. PubMed ID: 9415193
[TBL] [Abstract][Full Text] [Related]
10. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.
Tallman MS; Hakimian D
Blood; 1995 Oct; 86(7):2463-74. PubMed ID: 7670093
[No Abstract] [Full Text] [Related]
11. Pharmacology of purine nucleoside analogues.
Plunkett W; Gandhi V
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S67-74. PubMed ID: 9137959
[TBL] [Abstract][Full Text] [Related]
12. Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Van den Neste E; Cardoen S; Offner F; Bontemps F
Int J Oncol; 2005 Oct; 27(4):1113-24. PubMed ID: 16142330
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
Saven A
Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
[No Abstract] [Full Text] [Related]
14. Purine analogues in the management of lymphoproliferative diseases.
Johnson SA
Clin Oncol (R Coll Radiol); 1996; 8(5):289-96. PubMed ID: 8934048
[TBL] [Abstract][Full Text] [Related]
15. Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms.
Pettitt AR; Clarke AR; Cawley JC; Griffiths SD
Br J Haematol; 1999 Jun; 105(4):986-8. PubMed ID: 10554810
[TBL] [Abstract][Full Text] [Related]
16. Older and new purine nucleoside analogs for patients with acute leukemias.
Robak P; Robak T
Cancer Treat Rev; 2013 Dec; 39(8):851-61. PubMed ID: 23566572
[TBL] [Abstract][Full Text] [Related]
17. New antimetabolites in the treatment of human malignancies.
Cheson BD
Semin Oncol; 1992 Dec; 19(6):695-706. PubMed ID: 1361080
[TBL] [Abstract][Full Text] [Related]
18. Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines.
Bastin-Coyette L; Cardoen S; Smal C; de Viron E; Arts A; Amsailale R; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2011 Mar; 81(5):586-93. PubMed ID: 21168391
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on purine analogues.
Cheson BD
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
[TBL] [Abstract][Full Text] [Related]
20. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
Pettitt AR; Sherrington PD; Cawley JC
Cancer Res; 2000 Aug; 60(15):4187-93. PubMed ID: 10945628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
